4 free views remaining today

De Sanctis-Cacchione syndrome

Description

De Sanctis-Cacchione syndrome, also known as DeSanctis–Cacchione syndrome, is a rare genetic disorder characterized by the combination of skin and eye symptoms of xeroderma pigmentosum (XP) with severe neurological and developmental involvement.

Key Features:

  • Cutaneous photosensitivity: extreme sensitivity to sunlight, leading to skin damage and pigmentation changes
  • Microcephaly: small head size
  • Mental retardation: intellectual disability
  • Short stature: growth delays and short height
  • Hypogonadism: underdeveloped reproductive organs
  • Spasticity: muscle stiffness and weakness
  • Peripheral neuropathy: nerve damage affecting the limbs

Additional Information:

  • The syndrome is inherited in an autosomal recessive manner, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.
  • De Sanctis-Cacchione syndrome is characterized by severe neurological symptoms, including mental retardation and short stature, which distinguish it from xeroderma pigmentosum alone.

References:

  • [1] Cutaneous photosensitivity, microcephaly, mental retardation, short stature, hypogonadism, spasticity, peripheral neuropathy, and other severe neurological symptoms are characteristic of De Sanctis-Cacchione syndrome. (Source: [4])
  • The combination of skin and eye symptoms of XP with severe neurological involvement is a hallmark of this rare genetic disorder. (Source: [5], [8])
  • DeSanctis–Cacchione syndrome is an autosomal recessive syndrome consisting of xeroderma pigmentosum associated with severe neurological and developmental involvement. (Source: [7])

Additional Characteristics

  • Spasticity
  • Short stature
  • Microcephaly
  • Mental retardation
  • Peripheral neuropathy
  • Hypogonadism
  • Cutaneous photosensitivity

Signs and Symptoms

De Sanctis-Cacchione syndrome is a rare genetic disorder characterized by a combination of skin and eye symptoms, along with neurological abnormalities.

Skin and Eye Symptoms

  • Excessive freckling and blistering after exposure to ultraviolet light (photosensitivity) [1]
  • Skin atrophy
  • Telangiectasia
  • Mottled hyperpigmentation and hypopigmentation [8]

These skin and eye symptoms are similar to those found in xeroderma pigmentosum, a condition that causes a heightened sensitivity to light.

Neurological Abnormalities

  • Mental retardation or intellectual disability [4][5][6][9]
  • Spasticity
  • Ataxia
  • Microcephaly (small head size)
  • Epilepsy
  • Deafness
  • Areflexia (absence of deep tendon reflexes)
  • Choreoathetosis (involuntary movements)

These neurological abnormalities can vary in severity and may be present from birth or develop over time.

Other Symptoms

  • Dwarfism (unusually short stature) [10][12]
  • Hypogonadism (underdevelopment of the testes or ovaries) [10][12]

It's worth noting that De Sanctis-Cacchione syndrome is a rare and extremely severe form of xeroderma pigmentosum, with a significant impact on both physical and mental health.

References: [1] Context 1 [4] Context 4 [5] Context 5 [6] Context 6 [8] Context 8 [9] Context 9 [10] Context 10 [12] Context 12

Additional Symptoms

  • Telangiectasia
  • Epilepsy
  • Microcephaly (small head size)
  • Mental retardation or intellectual disability
  • Choreoathetosis (involuntary movements)
  • Skin atrophy
  • Areflexia (absence of deep tendon reflexes)
  • Excessive freckling and blistering after exposure to ultraviolet light (photosensitivity)
  • Hypogonadism (underdevelopment of the testes or ovaries)
  • ataxia
  • deafness
  • hyperpigmentation
  • short stature
  • spasticity

Diagnostic Tests

De Sanctis-Cacchione syndrome, also known as xeroderma pigmentosum with neurological abnormalities, is a rare inherited disorder characterized by extreme sunlight sensitivity, skin atrophy and pigmentation, skin tumors, and neurological and intellectual deficits.

Diagnostic Tests:

  • Specialized laboratory tests may be used to confirm a diagnosis of De Sanctis-Cacchione syndrome. These tests can detect defective DNA repair in white blood cells (lymphocytes), liver cells, corneal cells, and skin cells taken from people affected by De Sanctis-Cacchione syndrome [1].
  • Molecular genetic testing is recommended for confirmation of the patient's mutation and complementation group characterization [3]. This test can identify mutations in the ERCC6 gene that cause this Syndrome.
  • Chromosomal breakage studies, complementation studies, and gene sequencing to identify the specific gene responsible for the condition may also be conducted [6].
  • A histopathologic examination of the facial skin biopsies may indicate a diagnosis of squamous cell carcinoma (SCC) [4] and [7].

Other Diagnostic Methods:

  • Clinical features such as neurological abnormalities, mental retardation, dwarfism, hypogonadism, and xeroderma pigmentosum can also be used to diagnose De Sanctis-Cacchione syndrome [9].
  • A complete blood count (CBC), sedimentation rate, urinalysis, chemistry panel, thyroid profile, VDRL test, quantitative stool fat, a sweat test, and other routine studies should include these tests for diagnosis [15].

It's worth noting that confirmatory molecular genetic testing is conducted for research purposes and is not routinely available [13].

Treatment

De Sanctis-Cacchione syndrome, also known as xeroderma pigmentosum with neurological abnormalities, is a rare genetic disorder characterized by extreme sensitivity to sunlight, skin tumors, and neurological deficits. While there is no cure for this condition, various treatments can help manage its symptoms.

Symptom-specific treatment

Treatment for De Sanctis-Cacchione syndrome is primarily symptom-specific, meaning it focuses on addressing the individual's specific needs and conditions. This may include:

  • Skin protection: Protecting the skin from further damage caused by sunlight is crucial. Patients are advised to use photoprotective measures such as clothing, hats, and sunscreen with high SPF.
  • Skin lesions management: Skin neoplasm management involves electrodessication, curettage, surgical excision, Mohs micrographic surgery, and chemoprevention (as mentioned in [6]). The goal is to prevent the growth of new skin tumors and manage existing ones.
  • Antibiotic therapy: In cases where patients develop infections, antibiotic therapy may be necessary (as seen in [5]).
  • Nutritional support: Patients with De Sanctis-Cacchione syndrome often require nutritional support, especially if they have difficulty swallowing or digesting food.

Chemoprevention

Chemoprevention is a treatment approach that aims to prevent the development of skin tumors and other complications associated with De Sanctis-Cacchione syndrome. While there is limited research on this topic, some studies suggest that chemoprevention may be beneficial in slowing down the progression of the disease (as mentioned in [1] and [9]).

Supportive care

In addition to symptom-specific treatment, supportive care plays a crucial role in managing De Sanctis-Cacchione syndrome. This includes:

  • Patient education: Educating patients and their families about the condition, its symptoms, and available treatments is essential.
  • Psychological support: Patients with De Sanctis-Cacchione syndrome often experience anxiety and other emotional challenges. Providing psychological support and counseling can help alleviate these issues.

It's essential to note that each patient's treatment plan will be tailored to their individual needs and circumstances. A qualified specialist should be consulted for personalized advice on managing De Sanctis-Cacchione syndrome.

References:

[1] Orphanet (2024) [5] Harrison, P. V., & Shuster, S. (2003) [6] Orphanet (2024) [9] Orphanet (2024)

Recommended Medications

  • Antibiotic therapy
  • Surgical excision
  • Nutritional support
  • Chemoprevention
  • Curettage
  • Photoprotective measures
  • Electrodessication
  • Mohs micrographic surgery

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

De Sanctis-Cacchione syndrome, also known as xeroderma pigmentosum with neurological abnormalities, is a rare genetic disorder that affects the body's ability to repair DNA damage caused by ultraviolet (UV) light. When considering the differential diagnosis of De Sanctis-Cacchione syndrome, several conditions should be taken into account.

  • Cockayne syndrome: This is a rare genetic disorder characterized by premature aging, intellectual disability, and other neurological abnormalities. It can present with similar symptoms to De Sanctis-Cacchione syndrome, such as photosensitivity and skin changes [6].
  • XP/Cockayne syndrome complex: This condition combines the features of xeroderma pigmentosum (XP) and Cockayne syndrome, making it a potential differential diagnosis for De Sanctis-Cacchione syndrome [5].
  • Trichothiodystrophy (TTD): TTD is a rare genetic disorder that affects the skin and nervous system. While it does not typically present with neurological abnormalities like De Sanctis-Cacchione syndrome, its symptoms can overlap with those of this condition, such as photosensitivity and brittle hair [2].
  • XP/Trichothiodystrophy complex: This is a rare combination of XP and TTD, which can present with similar symptoms to De Sanctis-Cacchione syndrome, including skin changes and neurological abnormalities [6].

It's essential to note that the differential diagnosis for De Sanctis-Cacchione syndrome involves considering these conditions in conjunction with clinical presentation and laboratory findings. A thorough evaluation by a qualified healthcare professional is necessary to accurately diagnose this condition.

References: [1] Not applicable [2] Context 2 [5] Context 5 [6] Context 6

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6668
owl#annotatedSource
t388224
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0112158
core#notation
DOID:0112158
oboInOwl#hasDbXref
UMLS_CUI:C0265201
IAO_0000115
A xeroderma pigmentosum characterized by xeroderma pigmentosum, short stature, intellectual disabilities, and progressive neurologic degeneration.
rdf-schema#label
De Sanctis-Cacchione syndrome
oboInOwl#hasExactSynonym
xeroderma pigmentosum with neurologic manifestation
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0050427
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.